Drug recall · August 26, 2026
Carbamazepine Tablets recall
Why: CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Carbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC 51672-4005-3.
- Lots / codes
Lot # AD94033, Exp Date: 5/31/2028.
- Quantity
- 1968 Bottles (1000Tablets/Bottle)
- Company
- Sun Pharmaceutical Industries Inc, Princeton, NJ
- Distribution
- US Nationwide.
- Initiated
- August 3, 2026 · Voluntary: Firm initiated
- Classified
- August 18, 2026
- Reported
- August 26, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Carbamazepine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.